Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy

被引：0
|
作者：
Elliott, P. [1 ]
Drachman, B. M. [2 ]
Gottlieb, S. S. [3 ]
Hoffman, J. E. [4 ]
Hummel, S. L. [5 ]
Lenihan, D. J. [6 ]
Ebede, B. [7 ]
Gundapaneni, B. [8 ]
Schwartz, J. H. [9 ]
Sultan, M. B. [9 ]
Shah, S. J. [10 ]
机构：
[1] UCL, London, England
[2] Univ Penn, Penn Presbyterian Med Ctr, Hlth Syst, Philadelphia, PA USA
[3] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[4] Univ Miami, Miami, FL USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Pfizer Inc, Collegeville, PA USA
[8] Pfizer Inc, Groton, CT USA
[9] Pfizer Inc, New York, NY USA
[10] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Dept Med, Chicago, IL 60611 USA
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1169
引用
收藏
页码：645 / 645
页数：1
相关论文
共 50 条
  • [31] Long-Term Use of Tafamidis in Transthyretin Familial Amyloid Polyneuropathy: A Single Center Experience
    Coelho, Teresa
    Silva, Ana
    Maia, Luis
    Mandel, Francine
    Rosas, Gregory
    Karayal, Onur
    NEUROLOGY, 2013, 80
  • [32] Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study
    Plante-Bordeneuve, Violaine
    Gorram, Farida
    Salhi, Hayet
    Nordine, Tarik
    Ayache, Samar S.
    Le Corvoisier, Philippe
    Azoulay, Daniel
    Feray, Cyrille
    Damy, Thibaud
    Lefaucheur, Jean-Pascal
    JOURNAL OF NEUROLOGY, 2017, 264 (02) : 268 - 276
  • [33] Beta-blocker exposure and long-term survival in patients with transthyretin amyloid cardiomyopathy
    Barge-Caballero, G.
    Barge Caballero, E.
    Lopez-Perez, M.
    Bilbao-Quesada, R.
    Gonzalez-Babarro, E.
    Gomez-Otero, I.
    Lopez-Lopez, A.
    Gutierrez-Feijoo, M.
    Varela-Roman, A.
    Gonzalez-Juanatey, C.
    Diaz-Castro, O.
    Crespo-Leiro, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1806 - 1806
  • [34] Long-term treatment with inotersen and potential improvement of amyloid transthyretin cardiomyopathy
    Dasgupta, N. R.
    Benson, M. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 140 - 140
  • [35] Long-Term Safety and Efficacy of AG10 in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study
    Judge, Daniel
    Heitner, Stephen B.
    Falk, Rodney H.
    Grogan, Martha
    Jacoby, Daniel L.
    Maurer, Mathew S.
    Selby, Van N.
    Shah, Sanjiv J.
    Witteles, Ronald
    Katz, Leonid
    Rao, Satish
    Sinha, Uma
    Fox, Jonathan
    CIRCULATION, 2019, 140 (25) : E966 - E967
  • [36] TAFAMIDIS IN THE TREATMENT OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY IN POLAND: EPIDEMIOLOGICAL DATA AND DEMOGRAPHIC DATA FROM AN EXPANDED ACCESS PROGRAM
    Sobczynska-Kilias, A.
    Kowalczyk, M.
    Konopka-Pliszka, M.
    Grzybowski, J.
    Jakubczyk, M.
    VALUE IN HEALTH, 2023, 26 (12) : S317 - S317
  • [37] Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy
    Marcia Waddington-Cruz
    Leslie Amass
    Denis Keohane
    Jeffrey Schwartz
    Balarama Gundapaneni
    Hui Hua Li
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [38] EARLY INTERVENTION WITH TAFAMIDIS PROVIDES LONG-TERM BENEFIT IN DELAYING NEUROLOGICAL PROGRESSION IN PATIENTS WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY
    Waddington-Cruz, M.
    Amass, L.
    Keohane, D. J.
    Schwartz, J.
    Li, H.
    Gundapaneni, B.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 244 - 244
  • [39] LONG-TERM EFFECTS OF TAFAMIDIS - A NEW THERAPEUTIC OPTION FOR PATIENTS WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY (TTR-FAP)
    Coelho, T.
    Maia, L.
    Martins da Silva, A.
    Waddington Cruz, M.
    Plante-Bordeneuve, V.
    Suhr, O. B.
    Conceicao, I.
    Schmidt, H.
    Trigo, P.
    Packman, J.
    Harnett, M.
    Grogan, D. R.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S543 - S543
  • [40] AN INTERIM ANALYSIS OF ALL-CASE POSTMARKETING SURVEILLANCE OF TAFAMIDIS MEGLUMINE FOR PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS AND PATIENT PROFILE IN JAPAN
    Hirano, Y.
    Ishii, T.
    Matsumoto, N.
    Takata, A.
    Sekijima, Y.
    Ueda, M.
    Ando, Y.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S12 - S12
12345